News
Popular searches: Influenza, Childhood cancer, Endometriosis, Inflammation
-
Clinician-researcher recognised with Monash Health leadership award
Dr Frances Milat has been acknowledged for her work as Head of Monash Health’s Metabolic Bone Service at Monash Health with the 2016 One Monash Health Award for Leadership in Excellence in Access and Responsiveness.… Read more
-
OCRF-funded projects to improve early detection, therapies for ovarian cancer
Hudson Institute researchers Dr Simon Chu and Dr Andrew Stephens have been awarded grants totalling more than $700,000 over three years by the Ovarian Cancer Research Foundation (OCRF), to support ongoing work to improve early-stage tumour detection and to develop better therapies for women with ovarian cancer.… Read more
-
Hudson Institute discovery could help ‘buy time’ during global avian influenza pandemic
A team of researchers at Hudson Institute of Medical Research have found that timely blocking of the body’s own immune response to infection from a severe or pathogenic strain of influenza could be vital in treating patients infected during a global pandemic.… Read more
-
Professor Robert McLachlan recognised in Queen’s Birthday Honours
Renowned Hudson researcher, clinical andrologist, and men’s health advocate, Professor Robert McLachlan has been made a Member of the Order of Australia in the 2016 Queen’s Birthday Honours.… Read more
-
Ritchie Centre researchers, students shine at fetal and neonatal conferences
Researchers and postgraduate students from The Ritchie Centre (Hudson Institute of Medical Research and Monash University) have shone at two of Australia’s biggest fetal and neonatal conferences, which both took place in Queensland last week.… Read more
-
Muscle mass crucial to preventing bone fractures in young people with cerebral palsy
Maintaining muscle mass is crucial for good bone health in young adults with cerebral palsy (CP), a new collaborative study by endocrinology researchers at Hudson Institute of Medical Research has found.… Read more
-
‘Bugs as drugs’: Harnessing novel gut bacteria for human health
Researchers are optimistic that a recent breakthrough allowing growth of the majority of human gut bacteria in the lab will lead to the development of new therapies for human health, replacing the use of faecal transplants in treating certain gut infections.… Read more
-
Science students become immunologists for a day at Hudson Institute of Medical Research
A group of students from the John Monash Science School experienced the future of science during a Discovery Tour at Hudson Institute of Medical Research to celebrate International Day of Immunology.… Read more
-
Hudson Director joins innovative ‘big data’ fight against cancer
Hudson Institute Director and distinguished cancer researcher Professor Bryan Williams has been invited to speak at a Hope Funds for Cancer Research meeting in New York.… Read more
-
$2 million funding for prostate, bowel cancer trial brings personalised medicine a step closer
Targeted genetic treatment for cancer is a step closer, with a world-first clinical trial set to test the effectiveness of a new class of drugs called BET inhibitors in treating prostate and colorectal cancer. A team of clinicians and researchers at Hudson Institute of Medical Research and Monash University has been awarded a $2 million… Read more